These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9655259)

  • 21. Prostate-specific antigen levels among cirrhotic patients.
    Akdogan M; Hassoun BS; Gurakar A; El-Sahwi K; Jazzar A; Wright H; Sebastian A; Nour B
    Int J Biol Markers; 2002; 17(3):161-4. PubMed ID: 12408465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine patterns in patients with benign and malignant prostatic diseases.
    Schatzl G; Reiter WJ; Thürridl T; Waldmüller J; Roden M; Söregi S; Madersbacher S
    Prostate; 2000 Aug; 44(3):219-24. PubMed ID: 10906738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of benign prostatic hyperplasia, testosterone and age on serum levels of prostate specific antigen.
    Aus G; Bergdahl S; Hugosson J; Lodding P; Norlén L
    Scand J Urol Nephrol; 1994 Dec; 28(4):379-84. PubMed ID: 7533925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PSA/volume ratio in prostatic disease in the elderly].
    Bo M; Ventura M; Massaia M; Fabris F
    Recenti Prog Med; 2001 Oct; 92(10):594-8. PubMed ID: 11695303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
    Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: results of the Tyrol Prostate Specific Antigen Screening Project.
    Horninger W; Volgger H; Rogatsch H; Strohmeyer D; Steiner H; Hobisch A; Klocker H; Bartsch G
    J Urol; 2001 Apr; 165(4):1143-5. PubMed ID: 11257656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of relations between serum levels of epitestosterone, estradiol, testosterone, IGF-1 and prostatic specific antigen in men with benign prostatic hyperplasia and carcinoma of the prostate.
    Hill M; Bílek R; Safarík L; Stárka L
    Physiol Res; 2000; 49 Suppl 1():S113-8. PubMed ID: 10984080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigative clinical study on prostate cancer part IV: exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients.
    Porcaro AB; Petrozziello A; Migliorini F; Lacola V; Romano M; Sava T; Ghimenton C; Caruso B; Zecchini Antoniolli S; Rubilotta E; Monaco C; Comunale L
    Urol Int; 2011; 86(4):399-406. PubMed ID: 21508618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer.
    Gonzalez-Barcena D; Vadillo-Buenfil M; Gomez-Orta F; Fuentes Garcia M; Cardenas-Cornejo I; Graef-Sanchez A; Comaru-Schally AM; Schally AV
    Prostate; 1994; 24(2):84-92. PubMed ID: 7508623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia.
    Marberger M; Roehrborn CG; Marks LS; Wilson T; Rittmaster RS
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1323-8. PubMed ID: 16434455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia.
    Mochtar CA; Kiemeney LA; van Riemsdijk MM; Barnett GS; Laguna MP; Debruyne FM; de la Rosette JJ
    Eur Urol; 2003 Dec; 44(6):695-700. PubMed ID: 14644122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma.
    Cetinkaya M; Günçe S; Ulusoy E; Aksoy F; Yildiz O; Adsan O; Ozden C
    Int Urol Nephrol; 1998; 30(5):581-5. PubMed ID: 9934801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.
    Stephan C; Lein M; Jung K; Schnorr D; Loening SA
    Cancer; 1997 Jan; 79(1):104-9. PubMed ID: 8988733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impacts of electroacupuncture on benign prostatic hyperplasia and the levels of estrogen and androgen in patients].
    Zheng R; Hu H
    Zhongguo Zhen Jiu; 2017 Jun; 37(6):599-602. PubMed ID: 29231500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients.
    Porcaro AB; Migliorini F; Romano M; Petrozziello A; Antoniolli SZ; Rubilotta E; Lacola V; Sava T; Ghimenton C; Caruso B; Monaco C; Comunale L
    Int Urol Nephrol; 2010 Sep; 42(3):673-81. PubMed ID: 19902378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
    Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
    J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia.
    Liu CC; Wang CJ; Huang SP; Chou YH; Wu WJ; Huang CH
    Kaohsiung J Med Sci; 2004 Jun; 20(6):273-8. PubMed ID: 15253468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
    Jhang JF; Jiang YH; Kuo HC
    Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.